Wellington Management Group LLP Boosts Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Wellington Management Group LLP grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 204,979 shares of the pharmacy operator’s stock after purchasing an additional 11,453 shares during the period. Wellington Management Group LLP’s holdings in Walgreens Boots Alliance were worth $1,912,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in WBA. First Financial Corp IN increased its stake in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares during the last quarter. Golden State Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Riverview Trust Co increased its position in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth $28,000. Finally, TD Private Client Wealth LLC boosted its position in Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $10.78 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.83. The stock has a market cap of $9.32 billion, a PE ratio of -1.05, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. The stock has a fifty day moving average of $10.75 and a 200-day moving average of $10.07.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $38.59 billion during the quarter, compared to analyst estimates of $37.90 billion. During the same quarter in the previous year, the firm earned $1.20 EPS. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

WBA has been the subject of several research analyst reports. Royal Bank of Canada raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. StockNews.com began coverage on shares of Walgreens Boots Alliance in a research note on Friday. They set a “hold” rating for the company. Finally, Bank of America upped their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.